Dendritic cells are preferentially targeted among hematolymphocytes by modified vaccinia virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo

BMC Immunology

Volumn 9, Issue , 2008, Pages

  Liu, Luzheng ^a,b   Chavan, Rahul ^b,c   Feinberg, Mark B ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN; NUCLEOPROTEIN; NUCLEOPROTEIN PEPTIDE 394 408, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NUCLEOPROTEIN PEPTIDE 394-408, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PEPTIDE FRAGMENT; SMALLPOX VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOID CELL; MODIFIED VACCINIA VIRUS ANKARA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS STRAIN; ANIMAL; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CELL LINE; CHICK EMBRYO; CULTURE TECHNIQUE; CYTOTOXICITY; GENE VECTOR; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; VIROLOGY;

ANIMALS; ANTIGEN PRESENTATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CHICK EMBRYO; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GENETIC VECTORS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; SMALLPOX VACCINE; T-LYMPHOCYTES; VACCINIA VIRUS;

EID: 42949155679     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-9-15     Document Type: Article

References (58)

1. Willis NJ Edward Jenner and the eradication of smallpox Scott Med J 1997, 42(4):118-121. 9507590
2. Neff JM Levine RH Lane JM Ager EA Moore H Rosenstein BJ Millar JD Henderson DA Complications of smallpox vaccination United States 1963. II. Results obtained by four statewide surveys Pediatrics 1967, 39(6):916-923. 4381735
3. Neff JM Lane JM Pert JH Moore R Millar JD Henderson DA Complications of smallpox vaccination. I. National survey in the United States, 1963 New England Journal of Medicine 1967, 276(3):125-132. 4381041
4. Mayr A Stickl H Muller HK Danner K Singer H [The smallpox vaccination strain MVA: Marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)] Zentralbl Bakteriol [B] 1978, 167(5-6):375-390. 219640
5. Meyer H Sutter G Mayr A Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence J Gen Virol 1991, 72(Pt 5):1031-1038. 2033387
6. Sutter G Moss B Nonreplicating vaccinia vector efficiently expresses recombinant genes Proceedings of the National Academy of Sciences of the United States of America 1992, 89(22):10847-10851. 50439 1438287 10.1073/ pnas.89.22.10847
7. Ramirez JC Gherardi MM Esteban M Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: Virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine Journal of virology 2000, 74(2):923-933. 111613 10623755 10.1128/JVI.74.2.923-933.2000
8. Wyatt LS Earl PL Eller LA Moss B Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge Proceedings of the National Academy of Sciences of the United States of America 2004, 101(13):4590-4595. 384791 15070762 10.1073/pnas.0401165101
9. Earl PL Americo JL Wyatt LS Eller LA Whitbeck JC Cohen GH Eisenberg RJ Hartmann CJ Jackson DL Kulesh DA Martinez MJ Miller DM Mucker EM Shamblin JD Zwiers SH Huggins JW Jahrling PB Moss B Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox Nature 2004, 428(6979):182-185. 10.1038/nature02331 15014500
10. Belyakov IM Earl P Dzutsev A Kuznetsov VA Lemon M Wyatt LS Snyder JT Ahlers JD Franchini G Moss B Berzofsky JA Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses Proceedings of the National Academy of Sciences of the United States of America 2003, 100(16):9458-9463. 170940 12869693 10.1073/pnas.1233578100
11. Drexler I Staib C Sutter G Modified vaccinia virus Ankara as antigen delivery system: How can we best use its potential? Curr Opin Biotechnol 2004, 15(6):506-512. 10.1016/j.copbio.2004.09.001 15560976
12. Kastenmuller W Drexler I Ludwig H Erfle V Peschel C Bernhard H Sutter G Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity Virology 2006, 350(2):276-288. 10.1016/j.virol.2006.02.039 16595141
13. Henderson DA The looming threat of bioterrorism Science 1999, 283(5406):1279-1282. 10.1126/science.283.5406.1279 10037590
14. Parrino J McCurdy LH Larkin BD Gordon IJ Rucker SE Enama ME Koup RA Roederer M Bailer RT Moodie Z Gu L Yan L Graham BS Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naive and vaccinia-immune individuals Vaccine 2007, 25(8):1513-1525. 1892755 17126963 10.1016/ j.vaccine.2006.10.047
15. Carroll MW Overwijk WW Chamberlain RS Rosenberg SA Moss B Restifo NP Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: A murine tumor model Vaccine 1997, 15(4):387-394. 1950787 9141209 10.1016/S0264-410X(96)00195-8
16. Carroll MW Moss B Poxviruses as expression vectors Curr Opin Biotechnol 1997, 8(5):573-577. 10.1016/S0958-1669(97)80031-6 9353230
17. Guermonprez P Valladeau J Zitvogel L Thery C Amigorena S Antigen presentation and T cell stimulation by dendritic cells Annu Rev Immunol 2002, 20:621-667. 10.1146/annurev.immunol.20.100301.064828 11861614
18. Drillien R Spehner D Hanau D Modified vaccinia virus Ankara induces moderate activation of human dendritic cells J Gen Virol 2004, 85(Pt 8):2167-2175. 10.1099/vir.0.79998-0 15269355
19. Liu L Xu Z Fuhlbrigge RC Pena-Cruz V Lieberman J Kupper TS Vaccinia virus induces strong immunoregulatory cytokine production in healthy human epidermal keratinocytes: A novel strategy for immune evasion Journal of virology 2005, 79(12):7363-7370. 1143660 15919891 10.1128/ JVI.79.12.7363-7370.2005
20. Engelmayer J Larsson M Subklewe M Chahroudi A Cox WI Steinman RM Bhardwaj N Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion J Immunol 1999, 163(12):6762-6768. 10586075
21. Humrich JY Thumann P Greiner S Humrich JH Averbeck M Schwank C Kampgen E Schuler G Jenne L Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells Eur J Immunol 2007, 37(4):954-965. 10.1002/eji.200636230 17357104
22. Walzer T Galibert L De Smedt T Poxvirus semaphorin A39R inhibits phagocytosis by dendritic cells and neutrophils Eur J Immunol 2005, 35(2):391-398. 10.1002/eji.200425669 15657950
23. Blanchard TJ Alcami A Andrea P Smith GL Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine J Gen Virol 1998, 79(Pt 5):1159-1167. 9603331
24. Chahroudi A Garber DA Reeves P Liu L Kalman D Feinberg MB Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus Journal of virology 2006, 80(17):8469-8481. 1563888 16912297 10.1128/JVI.02749-05
25. Jung S Unutmaz D Wong P Sano G De los Santos K Sparwasser T Wu S Vuthoori S Ko K Zavala F Pamer EG Littman DR Lang RA In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens Immunity 2002, 17(2):211-220. 10.1016/ S1074-7613(02)00365-5 12196292
26. Tian T Woodworth J Skold M Behar SM In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection J Immunol 2005, 175(5):3268-3272. 16116218
27. Belyakov IM Wyatt LS Ahlers JD Earl P Pendleton CD Kelsall BL Strober W Moss B Berzofsky JA Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein Journal of virology 1998, 72(10):8264-8272. 110185 9733870
28. Chahroudi A Chavan R Kozyr N Waller EK Silvestri G Feinberg MB Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor Journal of virology 2005, 79(16):10397-10407. 1182677 16051832 10.1128/ JVI.79.16.10397-10407.2005
29. Amanna IJ Slifka MK Crotty S Immunity and immunological memory following smallpox vaccination Immunol Rev 2006, 211:320-337. 10.1111/ j.0105-2896.2006.00392.x 16824139
30. Crotty S Felgner P Davies H Glidewell J Villarreal L Ahmed R Cutting edge: Long-term B cell memory in humans after smallpox vaccination J Immunol 2003, 171(10):4969-4973. 14607890
31. Precopio ML Betts MR Parrino J Price DA Gostick E Ambrozak DR Asher TE Douek DC Harari A Pantaleo G Bailer R Graham BS Roederer M Koup RA Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses J Exp Med 2007, 204(6):1405-1416. 2118607 17535971 10.1084/jem.20062363
32. Behboudi S Moore A Gilbert SC Nicoll CL Hill AV Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction Vaccine 2004, 22(31-32):4326-4331. 10.1016/j.vaccine.2004.04.029 15474725
33. Behboudi S Moore A Hill AV Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells Cell Immunol 2004, 228(1):15-19. 10.1016/j.cellimm.2004.03.010 15203315
34. Bender A Albert M Reddy A Feldman M Sauter B Kaplan G Hellman W Bhardwaj N The distinctive features of influenza virus infection of dendritic cells Immunobiology 1998, 198(5):552-567. 9561373
35. Ho LJ Wang JJ Shaio MF Kao CL Chang DM Han SW Lai JH Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production J Immunol 2001, 166(3):1499-1506. 11160189
36. Geijtenbeek TB Kwon DS Torensma R van Vliet SJ van Duijnhoven GC Middel J Cornelissen IL Nottet HS KewalRamani VN Littman DR Figdor CG van Kooyk Y DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells Cell 2000, 100(5):587-597. 10.1016/ S0092-8674(00)80694-7 10721995
37. Moutaftsi M Mehl AM Borysiewicz LK Tabi Z Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells Blood 2002, 99(8):2913-2921. 10.1182/blood.V99.8.2913 11929782
38. Servet-Delprat C Vidalain PO Azocar O Le Deist F Fischer A Rabourdin-Combe C Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus Journal of virology 2000, 74(9):4387-4393. 111955 10756053 10.1128/JVI.74.9.4387-4393.2000
39. Servet-Delprat C Vidalain PO Bausinger H Manie S Le Deist F Azocar O Hanau D Fischer A Rabourdin-Combe C Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells J Immunol 2000, 164(4):1753-1760. 10657621
40. Oie KL Pickup DJ Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation Virology 2001, 288(1):175-187. 10.1006/viro.2001.1090 11543670
41. Yoshimura S Bondeson J Foxwell BM Brennan FM Feldmann M Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines Int Immunol 2001, 13(5):675-683. 10.1093/intimm/13.5.675 11312255
42. Seet BT Johnston JB Brunetti CR Barrett JW Everett H Cameron C Sypula J Nazarian SH Lucas A McFadden G Poxviruses and immune evasion Annual Review of Immunology 2003, 21:377-423. 10.1146/ annurev.immunol.21.120601.141049 12543935
43. Colamonici OR Domanski P Sweitzer SM Larner A Buller RM Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling J Biol Chem 1995, 270(27):15974-15978. 10.1074/jbc.270.27.15974 7608155
44. Symons JA Alcami A Smith GL Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity Cell 1995, 81(4):551-560. 10.1016/0092-8674(95)90076-4 7758109
45. Antoine G Scheiflinger F Dorner F Falkner FG The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses Virology 1998, 244(2):365-396. 10.1006/viro.1998.9123 9601507
46. Lande R Giacomini E Grassi T Remoli ME Iona E Miettinen M Julkunen I Coccia EM IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: Selective recruitment of NK and activated T cells Journal of Immunology 2003, 170(3):1174-1182. 12538673
47. Montoya M Schiavoni G Mattei F Gresser I Belardelli F Borrow P Tough DF Type I interferons produced by dendritic cells promote their phenotypic and functional activation Blood 2002, 99(9):3263-3271. 10.1182/ blood.V99.9.3263 11964292
48. Dobbelstein M Shenk T Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product Journal of virology 1996, 70(9):6479-6485. 190684 8709286
49. Norbury CC Malide D Gibbs JS Bennink JR Yewdell JW Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo Nat Immunol 2002, 3(3):265-271. 10.1038/ni762 11828323
50. Norbury CC Basta S Donohue KB Tscharke DC Princiotta MF Berglund P Gibbs J Bennink JR Yewdell JW CD8+ T cell cross-priming via transfer of proteasome substrates Science 2004, 304(5675):1318-1321. 10.1126/ science.1096378 15166379
51. Kennedy R Poland GA T-Cell epitope discovery for variola and vaccinia viruses Rev Med Virol 2007, 17(2):93-113. 10.1002/rmv.527 17195963
52. Chavan R Marfatia KA An IC Garber DA Feinberg MB Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses Journal of virology 2006, 80(15):7676-7687. 1563727 16840346 10.1128/JVI.02748-05
53. Carroll MW Moss B Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line Virology 1997, 238(2):198-211. 10.1006/viro.1997.8845 9400593
54. Pulendran B Lingappa J Kennedy MK Smith J Teepe M Rudensky A Maliszewski CR Maraskovsky E Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice J Immunol 1997, 159(5):2222-2231. 9278310
55. Pulendran B Smith JL Caspary G Brasel K Pettit D Maraskovsky E Maliszewski CR Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proceedings of the National Academy of Sciences of the United States of America 1999, 96(3):1036-1041. 15346 9927689 10.1073/pnas.96.3.1036
56. Liu L Usherwood EJ Blackman MA Woodland DL T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice Journal of virology 1999, 73(12):9849-9857. 113034 10559297
57. Sailaja G Husain S Nayak BP Jabbar AM Long-term maintenance of gp120-specific immune responses by genetic vaccination with the HIV-1 envelope genes linked to the gene encoding Flt-3 ligand J Immunol 2003, 170(5):2496-2507. 12594275
58. Liu L Chahroudi A Silvestri G Wernett ME Kaiser WJ Safrit JT Komoriya A Altman JD Packard BZ Feinberg MB Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates Nat Med 2002, 8(2):185-189. 10.1038/nm0202-185 11821904